产品名称
Phospho-LRRK2 (S935) Recombinant Rabbit Monoclonal Antibody [JE42-11]
抗体类型
Recombinant Rabbit monoclonal Antibody
免疫原
Synthetic phosphopeptide corresponding to residues surrounding Ser935 of human LRRK2 protein.
产品特异性
Phospho-LRRK2 (Ser935) [JE42-11] Antibody recognizes transfected levels of LRRK2 protein only when phosphorylated at Ser935.
靶点分子量
Predicted band size: 286 kDa
阳性对照
MEF treated with 1μM okadaic acid for 1 hour cell lysate, MEF treated with 100nM Calyculin A for 30 minutes cell lysate, NIH/3T3 cell lysate, MEF cells treated with 100nM Calyculin A for 30 minutes.
存放说明
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). Store at -20℃ long term.
存储缓冲液
1*TBS (pH7.4), 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
纯化方式
Protein A affinity purified.
功能
The LRRK2 gene encodes a protein with an armadillo repeats (ARM) region, an ankyrin repeat (ANK) region, a leucine-rich repeat (LRR) domain, a kinase domain, a RAS domain, a GTPase domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. LRRK2 interacts with the C-terminal R2 RING finger domain of parkin, and parkin interacted with the COR domain of LRRK2. Expression of mutant LRRK2 induced apoptotic cell death in neuroblastoma cells and in mouse cortical neurons. Expression of LRRK2 mutants implicated in autosomal dominant Parkinson's disease causes shortening and simplification of the dendritic tree in vivo and in cultured neurons. This is mediated in part by alterations in macroautophagy, and can be prevented by protein kinase A regulation of the autophagy protein LC3. The G2019S and R1441C mutations elicit post-synaptic calcium imbalance, leading to excess mitochondrial clearance from dendrites by mitophagy. LRRK2 is also a substrate for chaperone-mediated autophagy.
背景文献
1. Usmani A et al. The Cell Biology of LRRK2 in Parkinson\'s Disease. Mol Cell Biol. 2021 Apr
2. Rocha EM et al. LRRK2 and idiopathic Parkinson\'s disease. Trends Neurosci. 2022 Mar
亚细胞定位
Cytoplasmic vesicle, Perikaryon, Golgi apparatus membrane, Cell projection, axon, dendrite, Endoplasmic reticulum membrane, Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane, Endosome, Lysosome, Mitochondrion outer membrane, Cytoplasm, cytoskeleton.
别名
augmented in rheumatoid arthritis 17 antibody
AURA17 antibody
Dardarin antibody
Leucine rich repeat kinase 2 antibody
leucine rich repeat serine threonine protein kinase 2 antibody
Leucine-rich repeat serine/threonine-protein kinase 2 antibody
LRRK 2 antibody
LRRK2 antibody
LRRK2_HUMAN antibody
PARK 8 antibody
展开
augmented in rheumatoid arthritis 17 antibody
AURA17 antibody
Dardarin antibody
Leucine rich repeat kinase 2 antibody
leucine rich repeat serine threonine protein kinase 2 antibody
Leucine-rich repeat serine/threonine-protein kinase 2 antibody
LRRK 2 antibody
LRRK2 antibody
LRRK2_HUMAN antibody
PARK 8 antibody
PARK8 antibody
RIPK7 antibody
ROCO 2 antibody
ROCO2 antibody
折叠
-
☑ Cell treatment (CT)
Western blot analysis of Phospho-LRRK2 (S935) on different lysates with Rabbit anti-Phospho-LRRK2 (S935) antibody (HA722315) at 1/1,000 dilution.
Lane 1: MEF cell lysate (20 µg/Lane)
Lane 2: MEF treated with 1μM okadaic acid for 1 hour cell lysate (20 µg/Lane)
Lane 3: MEF cell lysate (20 µg/Lane)
Lane 4: MEF treated with 100nM Calyculin A for 30 minutes cell lysate (20 µg/Lane)
Lane 5: NIH/3T3 cell lysate (10 µg/Lane)
Lane 6: MEF treated with 100nM Calyculin A for 30 minutes cell lysate, then the membrane treated with λpp for 1 hour (20 µg/Lane)
Predicted band size: 286 kDa
Observed band size: 286 kDa
Exposure time: 3 minutes; ECL: K1801;
3-8% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (HA722315) at 1/1,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature.
-
☑ Cell treatment (CT)
Immunocytochemistry analysis of MEF cells treated with 100nM Calyculin A for 30 minutes labeling Phospho-LRRK2 (S935) with Rabbit anti-Phospho-LRRK2 (S935) antibody (HA722315) at 1/1,000 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-Phospho-LRRK2 (S935) antibody (HA722315) at 1/1,000 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (M1305-2, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution.
-
☑ Cell treatment (CT)
Flow cytometric analysis of MEF cells (left) and MEF cells treated with 100nM Calyculin A for 30 minutes (right) labeling Phospho-LRRK2 (S935).
Cells were fixed and permeabilized. Then stained with the primary antibody (HA722315, 1/1,000) (red) compared with Rabbit IgG Isotype Control (green). After incubation of the primary antibody at +4℃ for an hour, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Rabbit IgG Secondary antibody (HA1121) at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black).
请注意: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"